Critical Path Public Private Partnerships Clinical Trials Optional

The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute.

This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative.

This is in support of Critical Path Initiative


introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act.

This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance.

This funding opportunity will provide support, depending on availability of FDA funding.

Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $20,000,000


Relevant Nonprofit Program Categories



Obtain Full Opportunity Text:
Webpage with full NOFO and instructions

Additional Information of Eligibility:
Critical Path Institute

Full Opportunity Web Address:
https://tg.usembassy.gov/embassy/funding-opportunities/

Contact:


Agency Email Description:
terrin.brown@fda.hhs.gov

Agency Email:


Date Posted:
2024-01-04

Application Due Date:


Archive Date:
2024-04-03



Social Entrepreneurship
Spotlight



Rwanda as Social Entrepreneur Fund Beneficiary


The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.






More Federal Domestic Assistance Programs


Reclamation Rural Water Supply Program | Single Family Property Disposition | Family Planning_Service Delivery Improvement Research Grants | Assistive Technology | Conservation Activities by Youth Service Organizations |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders